BioAtla Inc (NAS:BCAB)
$ 1.91 -0.14 (-6.83%) Market Cap: 91.90 Mil Enterprise Value: 20.27 Mil PE Ratio: 0 PB Ratio: 1.85 GF Score: 36/100

Bioatla Inc at JMP Securities Life Sciences Conference Transcript

May 15, 2023 / 05:30PM GMT
Release Date Price: $3.87 (+5.45%)
Unidentified Analyst

Welcome to the JMP Securities Life Science Conference. It's my pleasure to introduce BioAtla. We've got the team up here, which is awesome. We have Jay, Philippe, and Sheri joining us. And just like in the audience as well as the webcast who listen to replays, I never know if they know much about the company.

So maybe, Jay, you could start off with just giving us an overview, three- to five-minute overview of the company.

Jay Short
BioAtla, Inc. - Chairman, CEO & Co-Founder

Yes. My pleasure, and thank you for inviting us. It's an honor to be here and to meet with several of our investors and potentially future investors. The company itself is headquartered in San Diego. Was started in 2007 and it really grew through strategic partnerships.

And one of the key objectives early on in this company was to focus on differentiated, not only technology, but ultimately different -- highly differentiated drugs that would address unmet medical need. And so one of the things that we developed over since those early years was a new

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot